Zhen Su

Zhen Su

Director/Board Member at KARYOPHARM THERAPEUTICS INC.

Net worth: - $ as of 2026-09-29

49 year
Health Technology
Consumer Services

Profile

Dr. Zhen Su is an Independent Director at CytomX Therapeutics, Inc., an Independent Director at Karyopharm Therapeutics, Inc. and a Chief Executive Officer & Director at Marengo Therapeutics, Inc. He is on the Board of Directors at CytomX Therapeutics, Inc., Karyopharm Therapeutics, Inc. and Marengo Therapeutics, Inc. Dr. Su was previously employed as a Chief Medical Officer by EMD Serono, Inc., a SVP & Global Head-Oncology Business by Merck KGaA, and a Director-Cell & Gene Therapy Program by University of Florida.
He received his MBA from the University of Toronto and a doctorate degree from Dresden University of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-16 0 ( -.--% ) - $ 2026-09-29
2026-03-29 0 ( -.--% ) - $ 2026-09-29

Zhen Su active positions

CompaniesPositionStart
KARYOPHARM THERAPEUTICS INC. Director/Board Member 2023-08-30
CYTOMX THERAPEUTICS, INC. Director/Board Member 2024-03-20
Chief Executive Officer 2021-06-30

Former positions of Zhen Su

CompaniesPositionEnd
MERCK KGAA Chief Tech/Sci/R&D Officer 2020-12-31
Chief Tech/Sci/R&D Officer 2018-12-31
Corporate Officer/Principal 2008-12-31
See the detail of Zhen Su's experience

Education of Zhen Su

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology